Trial Profile
Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pomaglumetad methionil (Primary)
- Indications Psychotic disorders
- Focus Pharmacokinetics
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2011 New trial record